Barely Significant
← all excerpts

Clinical potential of necitumumab in non-small cell lung carcinoma.

Onco Targets Ther · 2016 · PMC5012835 · PMID 27621656

1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

a trend toward significanceP =0.057so close (0.05 < p ≤ 0.1)
33 Finally, a retrospective analysis evaluated the value of EGFR gene copy number assessed with fluorescence in situ hybridization (FISH), as a predictor of outcome in 557 evaluable patients; although a positive FISH does not qualify as a predictor of outcome with statistical significance, a trend toward significance was observed for both PFS (interaction P =0.057) and OS (interaction P =0.066), and the addition of necitumumab in the FISH-positive population resulted in an HR equal to 0.71 for PFS (95% CI=0.52–0.97) and 0.70 for OS (95% CI=0.52–0.96). 34 Safety profile The different trials involving necitumumab allowed the investigators to collect meaningful data about its safety profile and the drug-related adverse events.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.